Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03173456 · ClinicalTrials.gov registry record · Phase 2
Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED)
A Phase 2 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 600
- Enrollment target
NCT03173456 is a Phase 2 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 600 participants.
The verdict
NCT03173456, a Phase 2 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 600 participants
- Enrollment target
Study Summary
This study compares the efficacy of five oral analgesics: 5 mg oxycodone + 325 mg acetaminophen, 5 mg hydrocodone + 300 mg acetaminophen, 30 mg codeine + 300 mg acetaminophen, 400 mg ibuprofen + 1000 mg acetaminophen, and 800 mg ibuprofen + 1000 mg acetaminophen for the treatment of patients with acute musculoskeletal pain who present to the Emergency Department (ED).
Interventions
- DRUG hydrocodone/APAP
- DRUG oxycodone/APAP
- DRUG codeine/APAP
- DRUG 400 ibuprofen/APAP
- DRUG 800 ibuprofen/APAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-11-28 |
| Est. Completion | 2019-11-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03173456
The ClinicalTrials.gov registry entry for NCT03173456 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which hydrocodone/APAP is the first listed.
NCT03173456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03173456 about?
NCT03173456 is a clinical study titled "Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED)". This study compares the efficacy of five oral analgesics: 5 mg oxycodone + 325 mg acetaminophen, 5 mg hydrocodone + 300 mg acetaminophen, 30 mg codeine + 300 mg acetaminophen, 400 mg ibuprofen + 1000 mg acetaminophen, and 800 mg ibuprofen + 1000 mg acetaminophen for the treatment of patients with ac...
What is the current status of trial NCT03173456?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 600 participants. The study started on 2017-11-28. Estimated completion is 2019-11-14.
What interventions are being tested in trial NCT03173456?
The interventions under investigation include: hydrocodone/APAP (DRUG), oxycodone/APAP (DRUG), codeine/APAP (DRUG), 400 ibuprofen/APAP (DRUG), 800 ibuprofen/APAP (DRUG).
Who is sponsoring clinical trial NCT03173456?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.